623 related articles for article (PubMed ID: 34887759)
1. Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease.
Wang Y; Gao L; Chen J; Li Q; Huo L; Wang Y; Wang H; Du J
Front Pharmacol; 2021; 12():757161. PubMed ID: 34887759
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 as a potential target for Parkinson's disease therapy.
Niu Y; Zhang J; Dong M
J Mol Med (Berl); 2021 Jul; 99(7):917-931. PubMed ID: 33844027
[TBL] [Abstract][Full Text] [Related]
3. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
4. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M
Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716
[TBL] [Abstract][Full Text] [Related]
6. 4-Hydroperoxy-2-decenoic acid ethyl ester protects against 6-hydroxydopamine-induced cell death via activation of Nrf2-ARE and eIF2α-ATF4 pathways.
Inoue Y; Hara H; Mitsugi Y; Yamaguchi E; Kamiya T; Itoh A; Adachi T
Neurochem Int; 2018 Jan; 112():288-296. PubMed ID: 28823537
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model.
Masaki Y; Izumi Y; Matsumura A; Akaike A; Kume T
Eur J Pharmacol; 2017 Mar; 798():26-34. PubMed ID: 28167258
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease.
Ahuja M; Kaidery NA; Dutta D; Attucks OC; Kazakov EH; Gazaryan I; Matsumoto M; Igarashi K; Sharma SM; Thomas B
Antioxidants (Basel); 2022 Sep; 11(9):. PubMed ID: 36139853
[TBL] [Abstract][Full Text] [Related]
9. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1.
Innamorato NG; Jazwa A; Rojo AI; García C; Fernández-Ruiz J; Grochot-Przeczek A; Stachurska A; Jozkowicz A; Dulak J; Cuadrado A
PLoS One; 2010 Jul; 5(7):e11838. PubMed ID: 20676377
[TBL] [Abstract][Full Text] [Related]
10. Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling.
Baluchnejadmojarad T; Rabiee N; Zabihnejad S; Roghani M
Brain Res; 2017 May; 1662():23-30. PubMed ID: 28238669
[TBL] [Abstract][Full Text] [Related]
11. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
12. BRUP-1, an intracellular bilirubin modulator, exerts neuroprotective activity in a cellular Parkinson's disease model.
Kataura T; Saiki S; Ishikawa KI; Akamatsu W; Sasazawa Y; Hattori N; Imoto M
J Neurochem; 2020 Oct; 155(1):81-97. PubMed ID: 32128811
[TBL] [Abstract][Full Text] [Related]
13. [Effect and mechanism of moxibustion on oxidative stress injury in rats with Parkinson's disease by activating Nrf2/ARE pathway].
Liu XL; Lu J; Tian Y; Zhang GY; Zhao CP; Wang TT; Li XR; Zhu ML
Zhongguo Zhen Jiu; 2020 Aug; 40(8):857-62. PubMed ID: 32869595
[TBL] [Abstract][Full Text] [Related]
14. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells.
Sun Y; He L; Wang T; Hua W; Qin H; Wang J; Wang L; Gu W; Li T; Li N; Liu X; Chen F; Tang L
Mol Neurobiol; 2020 Nov; 57(11):4628-4641. PubMed ID: 32770451
[TBL] [Abstract][Full Text] [Related]
15. Role of Astrogliosis in the Pathogenesis of Parkinson's Disease: Insights into Astrocytic Nrf2 Pathway as a Potential Therapeutic Target.
Bhushan B; Singh NK
CNS Neurol Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37817521
[TBL] [Abstract][Full Text] [Related]
16. Glaucocalyxin B Alleviates Lipopolysaccharide-Induced Parkinson's Disease by Inhibiting TLR/NF-κB and Activating Nrf2/HO-1 Pathway.
Xu W; Zheng D; Liu Y; Li J; Yang L; Shang X
Cell Physiol Biochem; 2017; 44(6):2091-2104. PubMed ID: 29241205
[TBL] [Abstract][Full Text] [Related]
17. Gastrodin protects against MPP(+)-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells.
Jiang G; Hu Y; Liu L; Cai J; Peng C; Li Q
Neurochem Int; 2014 Sep; 75():79-88. PubMed ID: 24932697
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-153 promotes oxidative stress in MPP
Zhu J; Wang S; Qi W; Xu X; Liang Y
Int J Clin Exp Pathol; 2018; 11(8):4179-4187. PubMed ID: 31949812
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara.
Lee J; Song K; Huh E; Oh MS; Kim YS
Redox Biol; 2018 Sep; 18():6-15. PubMed ID: 29890337
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1.
Inose Y; Izumi Y; Takada-Takatori Y; Akaike A; Koyama Y; Kaneko S; Kume T
Neurosci Lett; 2020 Sep; 736():135268. PubMed ID: 32712353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
